Clinical effects of Hange-shashin-to on combination therapy of S-1/Irinotecan against the for patients with metastatic gastric and colorectal cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 9, 2009, Pages 1485-1488

  Hibi, Satoshi ^a   Ina, Kenji ^a   Furuta, Ryuichi ^a   Kataoka, Takae ^a   Kojima, Shinobu ^a   Kawai, Masaru ^a  

^a Nagoya Memorial Hospital   (Japan)

Author keywords

Hange shashin to; QOL; S 1 CPT 11 combination therapy

Indexed keywords

GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HANGE SHASHIN TO; IRINOTECAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HUMAN; METASTATIC GASTRIC CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH CANCER; UNSPECIFIED SIDE EFFECT;

EID: 79959815413     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Shimada Y, Yoshino M, Wakui A, et al: Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J Clin Oncol 11: 909-913, 1993. (Pubitemid 23146086)
2. Takiuchi H, Narahara H, Tsujinaka T, et al: Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002). Jpn J Clin Oncol 35: 520-525, 2005. (Pubitemid 41573941)
3. Komatsu Y, Yuuki S, Fuse N, et al: Phase II study of oral S-1 plus irinotecan in patients with advanced colorectal cancer. Jpn J Clin Oncol 35: 88-89, 2005.
4. Kurihara M, Shimizu H, Tsuboi K, et al: Development of quality of life questionnaire in Japan: Quality of life assessment of cancer patients receiving chemotherapy. Psychooncology 8: 355-363, 1999. (Pubitemid 29417490)
5. Kase Y, Hayakawa T, Aburada M, et al: Preventive effects of Hange-shashin-to on irinotecan hydrochloride caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat. Jpn J Pharmacol 75: 407-413, 1997. (Pubitemid 28020074)
6. Yokoi T, Narita M, Nagai E, et al: Inhibition of UDP-glucuronosyl transferase by aglycons of natural glucuronides in Kampo medicines using SN-38 (7-etyl-10-hydroxylcamptothecin) as a substrate. Jpn J Cancer Res 86: 985-989, 1996.